Type I IFN signaling through CD8α+ DCs is crucial for development of cancer cell-specific cytotoxic T lymphocytes (CTLs) in animal models, suggesting that type I IFN induction through RLRs activated by Ads could play an important in the development of anti-tumor immunity (especially CTLs). The gene discussed is CD8A; the disease is neoplasm.